Business Wire - November 19, 2002
As part of the registration process in Nigeria, the Company was required to send VScan(TM) Rapid Test Kits to the Mainland Hospital for "Infectious Disease" in the Lagos State, Nigeria. The results of the testing from the Hospital show that the VScan(TM) Rapid Test Kits had 100% Sensitivity and 100% Specificity.
The report prepared by the hospital says "The VScan(TM) HIV Rapid Test Kits is highly efficient and has an edge over other screening Test Kits. VScan(TM) is made for an individual patient, thus bringing down the cost and time of screening a patient for HIV 1 and 2. It is also easy to use and interpret."
Nigeria has a significant HIV problem and the results obtained are an important step in the registration process. Once registration is obtained it would be reasonable to expect orders of 3 to 4 million HIV Test Kits per year.
About Medical Services International Inc.
Medical Services International Inc. is a medically related holding company with its head office in Edmonton, Canada. The diagnostic test division was created in response to a worldwide demand for less costly, rapid, technically simplified test methods to test for infectious diseases.
The Company has developed its VScan(TM) Rapid Test Kits for the detection of HIV 1 & 2, Hepatitis B & C and Tuberculosis. The Company is currently in negotiations with major healthcare concerns to supply these tests to the worldwide market. The test kits cannot be sold in Canada.
Medical Services International Inc. trades in the United States on the NQB Pink Sheets under the symbol "MSITF".
For further information, please contact Robert Talbot at 780/430-6363, or Bill Whitehead, Jr. at 416/822 5883 Corporate Website: www.MedicalServicesIntl.com
Note: Certain statements in this news release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include, but are not limited to new economic conditions, risk in product technology developments, market acceptance of new product and continuing product demand, level of competition and other factors described in the company reports, prospectus and other filings with the Securities and Exchange Commission.
CONTACT: Medical Services International Inc.
Robert Talbot, 780/430-6363
Bill Whitehead, Jr. 416/822-5883
www.MedicalServicesIntl.com
SOURCE: Medical Services International Inc.
021119
BW021110
Copyright © 2002 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .